A phase 1, open label, nonrandomized, crossover study was conducted to assess the effects of multiple once daily 240 mg oral doses of neratinib on the PK of a single 0.5 mg oral dose of digoxin in the fed state. Pharmacokinetics was available from 27 subjects given digoxin alone and 18 subjects receiving digoxin and neratinib.